Clinical Trials Browser

Phase NA × pyrotinib × 90 days × Clear all

NCT06495541 2026-03-20

The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive

Phase NA Not yet recruiting

Breast Neoplasms